Nath Bio-Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 29-12-2024
- Company Age 33 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.17 M
as on 29-12-2024
- Revenue %
(FY 2021)
- Profit 64.28%
(FY 2021)
- Ebitda 66.75%
(FY 2021)
- Net Worth -0.10%
(FY 2021)
- Total Assets 2.15%
(FY 2021)
About Nath Bio-Technologies
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹7.17 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Satish Kagliwal, Jeevanlata Kagliwal, and Sweta Kagliwal serve as directors at the Company.
- CIN/LLPIN
U01110MH1991PLC063077
- Company No.
063077
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Aug 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Nath Bio-Technologies?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satish Kagliwal  | Director | 27-Aug-1991 | Current |
| Jeevanlata Kagliwal | Director | 25-Mar-2019 | Current |
| Sweta Kagliwal | Director | 25-Mar-2019 | Current |
Financial Performance of Nath Bio-Technologies.
Nath Bio-Technologies Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 64.28% increase in profit. The company's net worth dipped by a decrease of 0.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nath Bio-Technologies?
In 2020, Nath Bio-Technologies had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nath Bio-Genes (India) LimitedActive 31 years 6 monthsSatish Kagliwal and Jeevanlata Kagliwal are mutual person
Agri-Tech (India) LimitedActive 31 years 5 monthsSatish Kagliwal, Jeevanlata Kagliwal and 1 more are mutual person
Techindia Nirman LimitedActive 44 years 2 monthsSatish Kagliwal and Jeevanlata Kagliwal are mutual person
Nath Holdings And Investments Pvt LtdActive 38 years 10 monthsJeevanlata Kagliwal is a mutual person
Charges (Loans)
₹0
₹0.72 Cr
Charges Breakdown by Lending Institutions
- State Bank Of Hydrabad : 0.69 Cr
- The Saraswat Cop Operative Baqnk Central Admin. : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 1994 | State Bank Of Hydrabad | ₹6.89 M | Satisfied |
| 14 May 1992 | The Saraswat Cop Operative Baqnk Central Admin. | ₹0.28 M | Satisfied |
How Many Employees Work at Nath Bio-Technologies?
Unlock and access historical data on people associated with Nath Bio-Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nath Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nath Bio-Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
